Trade ARDT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Ardent Health, Inc. (ARDT) is trading at US$10.48, down 2.06% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$1.55B. Over the past 52 weeks, ARDT has traded between US$7.71 and US$15.48. On Syfe you can trade ARDT with $0 commission and add it to your watchlist.
| Previous close | US$10.70 |
|---|---|
| Market cap | US$1.55B |
| P/E ratio | 9.47 |
| 52-week range | US$7.71 – US$15.48 |
| Volume | 501.99K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Ardent Health, Inc.
Ardent Health, Inc. engages in the provision of healthcare and related services. It also owns and operates hospitals through its subsidiaries. The company was founded in 1993 and is headquartered in Brentwood, TN.
Year: 2024
BofA Adjusts Price Target on Ardent Health Partners to $10 From $9
Aug 11, 12:14 PM · MT Newswires
BofA Securities Adjusts Ardent Health Partners Price Target to $10 From $9
Aug 10, 12:09 PM · MT Newswires
RBC Adjusts PT on Ardent Health Partners to $13 From $12, Maintains Outperform Rating
Aug 10, 10:48 AM · MT Newswires
Truist Adjusts Price Target on Ardent Health Partners to $13 From $12, Maintains Buy Rating
Aug 6, 10:47 AM · MT Newswires
-- Earnings Flash (ARDT) Ardent Health, Inc. Reports Q2 Revenue $1.62B, vs. FactSet Est of $1.59B
Aug 4, 8:27 PM · MT Newswires
Ardent Health, Inc. (ARDT) stock is trading at US$10.48, -2.06% from the previous close of US$10.70.
The market cap for Ardent Health, Inc. (ARDT) stock is approximately US$1.55B.
The price-to-earnings ratio for Ardent Health, Inc. (ARDT) is 9.47, based on the latest reported earnings.
The 52-week high for Ardent Health, Inc. (ARDT) stock is US$15.48.
The 52-week low for Ardent Health, Inc. (ARDT) stock is US$7.71.
Ardent Health, Inc. (ARDT) does not currently pay a dividend.
Stay on top of ARDT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
